Carani Sanjeevi

Carani Sanjeevi is a highly accomplished professional with extensive experience in medical research and academia. Currently serving on the Scientific and Business Advisory Board at Eir Ventures and as a member of the Scientific Advisory Board for Diamyd Medical, Carani has also held key positions at the Karolinska Institutet since 1996, including Associate Professor and Head of the Molecular Immunogenetics Group, focusing on autoimmune diabetes and related research. Other significant roles include Senior Advisor at the Innovation Office of Karolinska Institutet, Operating Advisor for Tata Capital Healthcare Private Equity Fund, and membership on the Scientific Advisory Boards of Seraxis Inc and Chellarams Diabetes Institute. Carani possesses a robust educational background, including a PhD in Molecular Medicine and Diabetes from Karolinska Institutet and a post-doc in Immunology from the University of Washington.